Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Carlsmed, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CARL
Nasdaq
3840
carlsmed.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Carlsmed, Inc.
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference
- Mar 7th, 2026 6:32 am
Carlsmed Q4 Earnings Call Highlights
- Feb 25th, 2026 10:07 pm
Carlsmed Inc (CARL) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...
- Feb 25th, 2026 10:03 pm
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
- Feb 25th, 2026 2:01 pm
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
- Feb 18th, 2026 2:05 pm
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
- Feb 11th, 2026 2:01 pm
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
- Feb 10th, 2026 7:00 am
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock
- Jan 22nd, 2026 4:20 am
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
- Jan 12th, 2026 6:05 am
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
- Jan 6th, 2026 2:05 pm
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
- Dec 9th, 2025 5:28 am
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
- Dec 3rd, 2025 5:00 am
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
- Nov 6th, 2025 2:01 pm
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
- Oct 23rd, 2025 2:01 pm
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
- Sep 29th, 2025 7:00 am
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
- Sep 22nd, 2025 7:00 am
Here’s Goldman Sachs’ Next S&P 500 Target — Plus 2 Top Stock Picks
- Sep 12th, 2025 4:02 am
UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results
- Aug 28th, 2025 4:09 pm
Carlsmed® Reports Second Quarter 2025 Financial Results
- Aug 28th, 2025 2:01 pm
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
- Aug 18th, 2025 12:25 pm
Scroll